GOSS - קצב צמיחת הכנסות משנה לשנה ב-12 החודשים האחרונים Gossamer Bio, Inc.

Gossamer Bio, Inc. (GOSS) brings together leading immunologists to combat severe lung pathologies, establishing a robust scientific foundation. Partnerships with global behemoths minimize financial risks while supporting free cash flow. Currently, resources are focused on advancing the core pipeline through strategic licensing. The annual revenue growth trend over the TTM period clearly demonstrates a trajectory, with the latest value recorded as 78.60.
gossamerbio.com (GOSS) - פילוחי מדדים ודוחות פיננסיים

For Gossamer Bio, Inc. (GOSS), which is protected by the humanitarian status of its pulmonary hypertension developments, this indicator serves as a filter for market noise by aggregating data over the last twelve months. By analyzing the annual revenue trend via the TTM metric, an investor can discern the actual sales growth rate, which, against a stable geopolitical backdrop, confirms the fundamental resilience of the company's business model.